Drug Patent Strategies
Companies often employ clever tactics to extend drug exclusivity by reformulating existing drugs, sometimes in seemingly trivial ways. By creating an enantiopure version of a drug, they can argue for extended patents based on slight improvements in bioavailability. This discussion sheds light on the intricate relationship between drug formulation and patent law, revealing how small changes can have significant implications for market competition.In this clip
From this podcast
The Jordan Harbinger Show
1053: Generic Drugs | Skeptical Sunday
Related Questions